Gilead Sciences, Inc. - Common Stock

By Insiderslab.com; Insiders.hk VANCOUVER, British Columbia, Feb. 7, 2012 -- /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Gilead Sciences (NASDAQ:GILD), Alpha Natural Resources ...

Boston-based Hambrecht & Quist Capital Management (HQCM), led by CEO & portfolio manager Daniel Omstead, and with over $475 million in 13-F assets per its latest Q4 filing on Friday, is the registered investment adviser to two closed-end equity funds, ...

By Karee Venema Following bullish earnings, Karee Venema of Schaeffer's Research writes that call buyers are piling in to one biopharmaceutical stock that has soared to three-year highs in just the last 60 days.

On January 18, I wrote a 2 part article giving a quick pick biopharma buy and sell list. Over 2 weeks later, we will revisit some of the original picks and commentary, then see how some of these picks are panning out.

By Derek Hoffman Micron Technology Inc. (NASDAQ:MU): After the death of Micron CEO Steve Appleton, Oppenheimer believes the company has a deep executive bench and several positive catalysts this year.